Augmented cell cycle protein expression and kinase activity in atherosclerotic rabbit vessels.
Cell proliferation within a primary atherosclerotic plaque is controversial. Identifying changes in cell cycle protein expression and the activities of their related kinases would provide valuable evidence of mitotic activity in the atherosclerotic lesion. Oxidized low-density lipoprotein has been shown to induce a significant increase in the total number of rabbit vascular smooth muscle cells in culture. In the present study, whole aortic cell extracts were harvested from rabbits fed a cholesterol-supplemented diet for eight weeks to induce modest plaque development, or 16 weeks to induce later, more severe plaque progression. Expression levels of cyclin A, cyclin-dependent kinase 4 (Cdk 4) and proliferating cell nuclear antigen were measured, as well as the activities of Cdk 4, Cdk 2 and Cdk 1. At both time points, the expression levels of cyclin A, Cdk 4 and proliferating cell nuclear antigen were significantly elevated. The activity of all three Cdks was also increased. There were no significant differences between moderate and more severe atherosclerosis. Surprisingly, tissues that neighboured the plaques, but did not show visible plaque formation on the vessel surface, also had significantly elevated cyclin A expression levels, but not as high as in the plaque areas. In conclusion, the primary atherosclerotic plaque exhibited elevated mitotic activity as shown by increased expression levels and activities of several cell cycle proteins. Expression levels were similar during moderate and severe atherosclerosis, and were even detected in nonatherosclerotic vascular tissue bordering the plaque.
Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, and Department of Physiology, Faculties of Medicine and Pharmacy, University of Manitoba, Winnipeg, Manitoba.
Marjorie E
ME
Zettler
Michele A
MA
Merchant
Grant N
GN
Pierce
Circ Res. 1999 Nov 26;85(11):1032-9
10571534
Biochemistry. 1991 Mar 5;30(9):2293-302
2001361
Circ Res. 1998 May 18;82(9):1007-15
9598598
Endocrinology. 1998 Aug;139(8):3432-41
9681493
Circ Res. 1998 Apr 6;82(6):713-21
9546380
Circ Res. 1986 Apr;58(4):427-44
3516443
J Surg Res. 1998 Jan;74(1):27-33
9536969
Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1370-80
12231554
Cell. 1994 Nov 18;79(4):547-50
7954820
J Clin Invest. 1994 Apr;93(4):1458-64
8163650
Arteriosclerosis. 1990 May-Jun;10(3):336-49
1693069
J Clin Invest. 1997 May 15;99(10):2334-41
9153274
Circ Res. 2000 Jan 7-21;86(1):15-23
10625300
Gene. 1994 Nov 4;149(1):13-9
7958977
Cell. 1994 Nov 18;79(4):563-71
7954823
Atherosclerosis. 1998 Jul;139(1):41-8
9699890
Circ Res. 1999 Nov 26;85(11):1040-5
10571535
Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H644-53
12529257
Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):727-32
14764420
J Clin Invest. 1993 Apr;91(4):1469-80
8097207
Arch Pathol (Chic). 1948 Aug;46(2):179-82
18106983
Nature. 1995 Mar 9;374(6518):131-4
7877684
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):601-7
12692004
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2394-402
17616740
Circ Res. 1962 Aug;11:329-36
13915914
J Biol Chem. 1996 Jul 26;271(30):17791-7
8663300
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8474-8
8104336
Cell. 1994 Nov 18;79(4):557-62
7954822
Clin Chim Acta. 1996 Mar 15;246(1-2):21-38
8814967
J Cell Physiol. 1995 Jun;163(3):577-88
7775600
Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1188-96
9672081
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2987-96
16844912
J Lipid Res. 1995 Sep;36(9):2005-16
8558088
J Cell Physiol. 1992 Nov;153(2):221-33
1358898
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Nature. 1993 Apr 29;362(6423):801-9
8479518
Biochem Biophys Res Commun. 1994 Jan 14;198(1):16-24
8292019